|
1
|
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.
|
J Neurosci
|
2005
|
1.52
|
|
2
|
Effects of newer antipsychotics on extrapyramidal function.
|
CNS Drugs
|
2002
|
1.50
|
|
3
|
Animal models of attention-deficit hyperactivity disorder.
|
Brain Res Brain Res Rev
|
2003
|
1.36
|
|
4
|
Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?
|
Expert Opin Biol Ther
|
2013
|
1.12
|
|
5
|
Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.
|
Pharmacol Ther
|
2011
|
1.03
|
|
6
|
Long-term effects of prenatal stress on dopamine and glutamate receptors in adult rat brain.
|
Neurochem Res
|
2002
|
1.00
|
|
7
|
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
|
J Pharmacol Exp Ther
|
2002
|
0.97
|
|
8
|
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects.
|
Synapse
|
2006
|
0.95
|
|
9
|
Regulation of working memory by dopamine D4 receptor in rats.
|
Neuropsychopharmacology
|
2004
|
0.93
|
|
10
|
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice.
|
J Mol Neurosci
|
2004
|
0.92
|
|
11
|
Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.
|
Eur Neuropsychopharmacol
|
2009
|
0.91
|
|
12
|
Effects of risperidone on dopamine receptor subtypes in developing rat brain.
|
Eur Neuropsychopharmacol
|
2006
|
0.90
|
|
13
|
Effects of risperidone on glutamate receptor subtypes in developing rat brain.
|
Eur Neuropsychopharmacol
|
2008
|
0.90
|
|
14
|
Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
|
Psychopharmacology (Berl)
|
2001
|
0.90
|
|
15
|
Early adoption modifies the effects of prenatal stress on dopamine and glutamate receptors in adult rat brain.
|
J Neurosci Res
|
2004
|
0.86
|
|
16
|
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
|
Int J Neuropsychopharmacol
|
2005
|
0.85
|
|
17
|
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
|
J Med Chem
|
2008
|
0.83
|
|
18
|
Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity.
|
Brain Res Dev Brain Res
|
2002
|
0.83
|
|
19
|
The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action.
|
Pharmacol Ther
|
2010
|
0.81
|
|
20
|
Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.
|
Bioorg Med Chem Lett
|
2006
|
0.81
|
|
21
|
R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands.
|
Bioorg Med Chem Lett
|
2007
|
0.80
|
|
22
|
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
|
Bioorg Med Chem Lett
|
2008
|
0.80
|
|
23
|
Repeated effects of asenapine on adrenergic and cholinergic muscarinic receptors.
|
Int J Neuropsychopharmacol
|
2009
|
0.80
|
|
24
|
Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning.
|
Neuropsychopharmacology
|
2002
|
0.79
|
|
25
|
Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
|
Psychopharmacology (Berl)
|
2002
|
0.79
|
|
26
|
Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.
|
J Mol Neurosci
|
2009
|
0.79
|
|
27
|
Alterations in dopamine and glutamate neurotransmission in tetrahydrobiopterin deficient spr-/- mice: relevance to schizophrenia.
|
BMB Rep
|
2010
|
0.78
|
|
28
|
Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex.
|
Synapse
|
2014
|
0.77
|
|
29
|
A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.
|
Biol Psychiatry
|
2012
|
0.77
|
|
30
|
Effects of prenatal stress on dopamine D2 receptor asymmetry in rat brain.
|
Synapse
|
2007
|
0.77
|
|
31
|
New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
|
J Med Chem
|
2012
|
0.77
|
|
32
|
Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors.
|
Eur Neuropsychopharmacol
|
2002
|
0.76
|
|
33
|
Pharmacological characterization of the norepinephrine and dopamine reuptake inhibitor EB-1020: implications for treatment of attention-deficit hyperactivity disorder.
|
Synapse
|
2012
|
0.76
|
|
34
|
Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
|
J Neurosci Res
|
2006
|
0.75
|
|
35
|
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
|
Bioorg Med Chem Lett
|
2008
|
0.75
|